Diabetes

Findings suggest cancer may have overtaken cardiovascular disease as a leading cause of death in individuals with type 2 diabetes.

In a phase 3 trial, empagliflozin significantly reduced the risk of kidney disease progression or cardiovascular death in adults with chronic kidney disease by 28% compared with placebo.

Community pharmacies are an untapped resource in rural areas but need to market their services to effect changes in public health.

High cost-sharing is a large barrier to insulin access, as are aspects of the Inflation Reduction Act of 2022.

The oral SGLT2 inhibitor has been shown to reduce blood sugar and improve glycemic control as an adjunct to diet and exercise.

The popularity of intermittent fasting, or time-restricted eating patterns, may not help control weight as well as other dieting methods.

Individuals with higher caffeine levels were less likely to have liver fibrosis, while higher levels of non-caffeine coffee components were associated with reduced fatty liver index scores.

An app using AI to evaluate blood sugar data, concerning trends, and recommend management tools will be a part of a clinical trial in 2024 for further assessment.

It is too early to know how patients could potentially change their microbiome to reduce their diabetes risk.

Label update removes a previous limitation that stated the medication should not be used as initial therapy for treating patients with type 2 diabetes.

Analysis focuses on why some individuals with a genetic predisposition develop AMD, while others are spared.

Risk is highest for those who are obese or who have diabetes, investigator from Keck Medicine and the University of Southern California indicate.

Analysis demonstrates that the tablets can significantly reduce the animals’ blood glucose levels for more than 5 hours.

The new CDC-approved app launched January 1, 2023.

A study showed that the risk of developing venous thromboembolism is worse for perimenopausal women with diabetes.

TD2 remission is defined as a hemoglobin A1C level of less than 6.5% at least 1 year after stopping medication, investigators say.

Pharmacists can provide guidance to administrators, teachers on insulin storage, dosage times.

Age was a contributing factor of chronic kidney disease and albuminuria in patients with type 1 and type 2 diabetes.

Relatives who attend low-intensity coaching and monitoring meetings increase individuals’ ability to manage the disease.

Commonly published metformin study designs in patients with type 2 diabetes may not be sufficiently addressing residual confounding.

Michelle Condren, PharmD, AE-C, BCPPS, CDCES, FPPA, discussed pharmacists' roles in inpatient diabetes management.

Teplizumab is a humanized IgG1κ Fc-nonbinding anti-CD3 monoclonal antibody that blocks T cells, preventing them from attacking beta cells.

An analysis found an estimated 1.3 million US adults with diabetes rationed their insulin in the past year by delaying prescription refills, skipping doses, or using smaller doses.

The implementation of negative control outcomes and a complementary cohort demonstrate an estimated beneficial effect that associated with an individual’s overall health.

Pharmacists play a significant role in the comprehensive management of this condition through education, intervention, and monitoring.